Antonini, F.M., Piva, G., Salvini, L., AND Sordi, A.: Lipoproteine ed eparina nel quadro umorale della chemiopatogenesi del l'aterosclerosi . Gior. Gerontol., suppl. Agosto1953.
3.
Hahn, P.F.: Abolishment of alimentary lipemia following injection of heparin. Science, 98: 19, 1943.
4.
Anfinsen, C.B. , Boyle, E., AND Brown, R.K.: The role of heparin in lipoprotein metabolism . Science, 115: 583, 1952.
5.
Korn, E.D.: Clearing factor, a heparin activated lipoprotein lipase; isolation and characterization of the enzyme from normal rat heart. J. Biol. Chem., 215: 1, 1955.
6.
Hollet, C., AND Meng, H.C.: Comparison of fat emulsion clearing activities of post-heparin plasma and pancreatic lipase. Am. J. Physiol., 184: 428, 1956.
7.
Engelberg, H.: Cited by Scardigli et al.13
8.
Block, W.S., Barker, N.M., AND Mann, F.D.: Effects of small doses of heparin in increasing the translucense of plasma during alimentary lipemia: studies in normal individuals and patients with atherosclerosis. Circulation, 4: 674, 1951.
9.
Litwins, J., Vorzimer, J.J., Sussman, L.N., Applezweig, N., AND Etess, A.D.: Sublingual administration of heparin. Proc. Soc. Exper. Biol. & Med., 77: 325, 1951.
10.
Macdevitt, E., Huebner, R.D., AND Wright, I.S.: Ineffectiveness of heparin by sublingual administration. J. A. M. A., 148: 1123, 1952.
Shaftel, H.E. , AND Selman, D.: The effect of sublingual heparin on hyperlipemic serum. Angiology, 10 : 131, 1959.
13.
Scardigli, G., Salvini, L., AND Aradas, A.: L'assorbimento del l'heparina per via sublinguale . Gior. gerontol., 3 : 120, 1955.
14.
Engelberg, H.: Buccal and sublingual administration of heparin potassium (Clarin); studies of plasma triglyceride lipolysis and heparin levels. J. A. M. A., 169 : 1322, 1959.
15.
Loomis, T.A. : Absorption of heparin from the intestine. ProcSoc. Exper. Biol. & Med.101: 447, 1959.
16.
Chandler, H.L. , Lawry, E.Y., Potee , K.G., AND Mann, G.V.: Spontaneous and induced variations in serum lipoproteinsCirculation , 8: 723, 1953.
17.
Dubler, H.., Pattay, J., Scheidegger, J.J., AND Berthaud E.: Etude comparative de l'effet de divers agents hypocholestérolémiants surle déséquilibre des lipoprotéines. Helvet. med. acta, 23: 635, 1956.
Cucurachi, L., AND Portioli, R.I.: Contributo allo studio della terapia degli stati dislipidemici. Gior. clin. med., 40: 1348, 1959 .
20.
Laborit, A. , Delga, J., Baylon , H., Hugo-Not, R., AND Dechen, J.: La therapeutique "Heparine-lipocaic" par administration sublinguale. Presse méd., 62: 79, 1954.
21.
Albrieux, A.S. , Deroca, F., Estefan , E.C., Pose, G., AND Paroli, P.: L'utilisation de l'heparine par voie orale dans le traitement de l'atherosclerose des membres et du cerveau. Concours Medical, 9: 857, 1954.
22.
Fortezza Bover, G., AND Tormo Alfonso , V.: La electroforesis en papel de los lypoproteidos del suero en la enfermedad coronaria y sus modificationes por la heparinalypocaica. Rev. españ. de cardiol., 10: 220, 1956.
23.
Mongini, M. , AND Federmucci, M.: Le traitement de l'Atherome par l'heparin perlinguale. Marseille-méd., 96: 157, 1959.
24.
Biancani, G. : Quadro lipoproteico della malattia aterosclerotica ed eparina perlingualeGior.clin. med., 39: 1900, 1958.
25.
Keller, R.: Neue Erkentnisse in der Therapie der Hypertonie. Praxis, 42: 12, 1953.
26.
Bardelli, S. , AND Zurlo, A.: Eparina e vasomotilita. Ricerche sulle modificazioni pressorie indotte dinamicamente dall'eparina in soggetti normotesi ed ipertesi . Settimana med. d. spero, 43: 466, 1955.